While such costs represent a small fraction of overall spending on health care, several dynamics help the prescription drug issue gain disproportionate attention.
Senior Correspondent John Daniel Davidson shares his reporting from the streets of San Francisco on the Federalist Radio Hour.
Reason Reporter Mike Riggs joins Federalist Radio to share the latest news and drug policy we are seeing from the new FDA commissioner.
We want success, and productive work requires focus. If you’re a rich kid micro-dosing amphetamines for school or career advantage, that’s rewarded.
Danish researchers have found there are approximately 13 additional breast cancer cases for every 100,000 women who use hormonal contraception for one year.
The rising costs of many, if not all, medications are largely the result of the lack of competition in the pharmaceutical industry. That’s the FDA’s fault.
Whereas physical health may be on the rise among teens in the iGen generation, their mental health and wellbeing has declined.
To date, research shows marijuana-based chemical compounds can be everything from anti-inflammatory to neuroprotective, with fewer side effects than pain drugs.
Addiction psychiatrist Sally Satel explains the unintended consequences of painkillers and how we arrived at this drug crisis on Federalist Radio.
After Vancouver implemented North America’s biggest needle-sharing program, its HIV and hepatitis rates exploded. So why are states following suit?
Urbanophile Aaron Renn discusses American cities, the opioid crisis, and the changing labor force on this episode of The Federalist Radio Hour.
Reporter and nutrition writer, Mike Riggs, joins the Federalist Radio Hour to share his transformation story.
In seeking to regulate human behavior at such a personal level as dictating what we may ingest, there is almost no alternative to Big Government.
America needs criminal justice reform, particularly to reduce the obstacles facing those reentering society. People who have served their time deserve a second chance in life.
With his experience and highly competent past FDA leadership, Trump nominee Scott Gottlieb will oversee all the FDA divisions with better scrutiny than the prior commissioner did.
If the president was truly concerned with solving the program, he would ditch the talking points and instead focus on what is needed to bring costs down.
On Wednesday, a Senate committee will hold a hearing on President Trump’s appointment of Dr. Scott Gottlieb as commissioner of the Food and Drug Administration.
While marijuana’s surface-level effects appear more benign than its detractors suggest, its unintended consequences run deeper than its advocates like to admit.
May the plant’s close brush with regulatory disaster be a lesson to citizens: the government doesn’t always hold our best interests as a top priority.
The GOP’s American Health Care Act, like Obamacare, does nothing to address the core drivers of health-care hyperinflation. Unless those issues are addressed, costs will continue to escalate.
- How The Code Name ‘Crossfire Hurricane’ Undermines The FBI’s Russia StoryThe paper of record has apparently joined a campaign, scontinue reading >
- I’m A Democrat, And The Left’s Russia Gaslighting Scares Me More Than Trump DoesMy fellow Democrats are increasingly becoming the kind continue reading >
- Why It’s Ridiculous To Say FBI Spying Meant To Protect The Trump CampaignThe decision to use Stefan Halper as an informant instecontinue reading >